Hovione announced today the appointment of Mr. Frédéric Kahn as Vice President Marketing and Sales, as of 1st September, 2017.
RDD Europe 2015 will be held from Tuesday 5th May until Friday 8th May 2015 at the Palais des Congres d'Antibes, Nice, France. Hovione will be present with a table (nr. 32), a presentation, a workshop and a set of posters.
Contact us if you would like to schedule a meeting or to find more about the Hovione posters at RDD.
Optimized Composite Particles for API-independent Formulations with Enhanced Performance
Speaker: Eunice Costa, PhD (Scientist, Drug Product Development)
Date: Friday, May 5, 2015
Time: 8:30 AM
Trends in Inhalation Drug Development: Particle Engineering and Formulation Strategies
Speakers: Eunice Costa, PhD (Scientist, Drug Product Development)
Filipe Neves, PhD (Senior Scientist, Group Leader, Drug Product Development)
Date: Wednesday, May 6, 2015
Time: tbd - afternoon from 2:00 to 6:00 PM
- Introduction: This workshop addresses trends in particle engineering (PE) technologies, and formulation strategies to overcome problems during the development of inhalation drugs. Participants will gain insight into innovative approaches via comprehensive and diverse case studies chosen to illustrate the complexity of manufacturing processes.
- Workshop Content: Participants will learn the fundamentals of inhalation delivery, together with an overview of market trends and basic concepts associated with metered dose inhalation (MDI) and dry powder inhalation (DPI); for the latter platform, carrier based and composite particles based approaches will be emphasized. The impact of different particle engineering technologies on the final performance of both MDI and DPI (carrier based) products will be discussed. Case studies will link API properties (measured by cutting edge techniques) and formulation strategy, with the overall success of a given delivery platform. Lastly, DPI formulation based on spray dried composite particle approaches will be explored using case studies covering formulation development and process scale-up.
- Outcome for Participants: The participants will gain insight into several innovative approaches, including a number of comprehensive and diverse case studies, which will illustrate the complex relationships linking inhaler design to particle engineering and formulation strategies.
Impact of the Size-Reduction Technology on the Performance of Suspension Pressurized Metered Dosed Inhalers: Benchmarking with Dry Powder Inhalers
Performance Optimization in Early DPI Development: Enabling High Dosage Drug Delivery to the Lungs Through Orifice-Based Aerosolization
Benchmarking Gravimetric FSI vs ACI: Can We Expedite Aerodynamic Performance Evaluation for Composite Powders?
Aerodynamic Performance of DPIs: Predicting the Impact of Carrier-Based Formulation Parameters
API Influence & Stability Assessment of Spray Dried Composite Particles
Optimizing Trade-Offs Between Product Performance and Process Efficiency via Powder Rheology